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Abstract
Kidney disease is a global problem with around three million people diagnosed in the UK alone and the incidence is rising.
Research is critical to develop better treatments. Animal models can help to better understand the pathophysiology behind the
various kidney diseases and to screen for therapeutic compounds, but the use especially of mammalian models should be
minimised in the interest of animal welfare. Zebrafish are increasingly used, as they are genetically tractable and have a basic
renal anatomy comparable to mammalian kidneys with glomerular filtration and tubular filtration processing. Here, we discuss
how zebrafish have advanced the study of nephrology and the mechanisms underlying kidney disease.
Keywords Kidney . Zebrafish . Chronic kidney disease . Polycystic kidney disease . Acute kidney injury . Animalmodel . Renal
diseases
Introduction
Kidney disease is a global problem with around three million
people diagnosed in the UK alone and up to a million people
undiagnosed [1]. Factors such as rising obesity, diabetes and
hypertension have been shown to play a role in the manifes-
tation of kidney dysfunction, but more research is needed to
understand the pathophysiology behind the disease. Animal
studies are a major tool in research, providing better under-
standing of normal physiology and mechanisms of disease
and to test potential therapies. Zebrafish (Danio rerio) have
been established as a model for development and reproduction
studies since the 1930s [2]. But advances in technology have
facilitated the growth of zebrafish as models to study organ-
specific diseases, such as kidney disorders.
Zebrafish embryos at the earlier stages of development (be-
fore 5.0 days post-fertilisation) are considered to experience
little to no pain and therefore are not protected under the animal
experimentation regulations, thus making them a useful re-
placement model for mammalian models, such as mice and rats
[3]. Zebrafish sperm can also be cryopreserved, reducing the
need for live culture and therefore decreasing resource use [4].
Zebrafish has advantages over mammalian models such as
mice (Mus musculus) in that pairings can produce a large
number (~ 50–200) of offspring that can grow to adulthood
within 3 months. This allows testing of various compounds
and even drug screening is feasible and potentially high
throughput. These embryos can be analysed for a phenotype
of interest rapidly due to their transparent nature, and pigment
can be reduced by chemical treatments and albino strains en-
abling phenotypic analysis at later stages [5]. They are espe-
cially useful for the study of genetic diseases, as they are very
amenable to genetic manipulations, such as through microin-
jections of DNA and RNA even at the one-cell stage of life.
With regards to homology between the two species,
there is high conservation of functional domains between
human and zebrafish proteins, where at least 70% of
zebrafish proteins have a human orthologue and 47% of
human genes have a one-to-one association with
orthologue in zebrafish [6]. Furthermore, genetic editing
techniques such as transcription activator-like effector nu-
cleases (TALENs), zinc finger nucleases and more recent-
ly, the Clustered regularly interspaced short palindromic
repeat (CRISPR)-Cas9 system can be easily employed in
the zebrafish to study gene function and the con-
sequences of its absence/modification.
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Zebrafish have long been used in other fields of research to
gain a better insight into various disease states. For example,
via the use of chemicals, tumours can be induced in a number
of organs proving to be useful models of cancer [7]. Zebrafish
adults from the c-mybhyper mutant line developed acute mye-
loid leukaemia-like or acute lymphoid leukaemia-like disor-
ders due to the hyperactivity of the transcription factor c-myb
(Myb proto-oncogene protein)—such abnormalities in man
lead to many haematopoietic disorders [8]. Zebrafish have
also been useful in the field of cardiology specifically in the
study of heart regeneration mechanisms and can show cardiac
failure when the same genes known to cause dilated cardio-
myopathy in humans are knocked down in the zebrafish [9]. A
significant amount of research has been carried out to study
renal function and disease using zebrafish. Here, we will re-
view kidney-related research in zebrafish and discuss the ad-
vantages and potential caveats involved of using this organism
as a model.
General aspects of the zebrafish model
Forward and reverse genetic approaches can easily be used in
the zebrafish to enable the study of genes. Forward genetic
approaches involve random mutagenesis in the embryo to
alter gene function and assessing phenotypes as a starting
point to find the causative gene [10]. Zebrafish screens are
feasible and were first used to identify genes involved in ver-
tebrate development [11].They have also shown to be success-
ful in isolating candidate genes responsible for human dis-
eases [12]. This is an unbiased approach in contrast to reverse
genetics in which a specific gene of interest is disrupted to
study the effects in the embryo.
A summary of the various genetic manipulations that can
be used in the zebrafish is described here:
Transient gene suppression: morpholinos
Another tool is the use of morpholinos which are targeted
antisense oligonucleotides withmodified bases that have com-
monly been used since the 1990s, to transiently knockdown a
gene of interest in zebrafish [13]. They were first employed in
the zebrafish in the 2000s and have the advantage of specifi-
cally blocking mRNA transcripts of interest with higher effi-
ciency than other antisense oligos [14]. They are useful as a
first approach to studying a particular gene or multiple genes
in the absence of a genetic mutant [15].
Nasevicius and Ekker (2000) were able to show
phenocopies for many known gene mutations such as the
one-eyed pinhead confirming that morpholinos can successful-
ly affect the majority of cells in the zebrafish [16]. It is essential
that the optimum dose of morpholino is determined to avoid
any pitfalls in mistaking the effect of toxicity as a gene-specific
phenotype. Morpholinos can often exhibit phenotypes which
are the result of off-target effects leading to uncertainty as to
whether the phenotype is truly the result of a knockdown of the
targeted gene. A common phenotype observed with
morpholinos consisting of neural toxicity had been shown to
be the result of activation of the p53 pathway [17]. These off-
target effects that trigger the p53 pathway have been shown to
be present in 15–20% of morpholino work injected at standard
concentrations and can be problematic for work involving
gene-specific activation of the p53 pathways [17]. Moreover,
injections of p53 morpholinos with the gene-specific
morpholino has become an important control step in
distinguishing true phenotypes from off-target effects [18].
A recent paper showed that when CRISPR/cas9-induced
mutants were examined alongside morpholino morphants,
they exhibited a milder phenotype suggesting that there are
wider off-target effects in the morpholino morphants that are
contributing to the severe phenotype [19]. It has been sug-
gested that milder phenotypes observed inmutants are thought
to be the result of compensatory mechanisms where subsets of
genes can be upregulated in response to loss of gene function
[20]. This was not observed in morphants with morpholino
use which can account for the more severe phenotypes but it
could also be said that morpholinos can show the function of a
gene more directly [15].The efficacy of the morpholinos is
typically limited to around 3 days post injection [21].
Though morpholinos can be assessed for phenotypes quite
rapidly they are transient, and it is more desirable to have a
stable mutant to study long term.
There is also a growing requirement to validate morpholino
work with genetic mutants so that phenotypes can be assessed
for gene specificity as well as studying the effects long term.
Determining the morpholino dose is also crucial and it is sug-
gested that phenocopying known mutants as a reference is a
suitable approach. Morpholinos should remain a valuable tool
in zebrafish research providing that other guidelines are follow-
ed along with appropriate genetic mutant controls [16, 22].
Forward genetic approaches
Random mutagenesis
The most common method of random mutagenesis uses the
methylating agent ethylnitrosourea (ENU) where exposure of
the mutagen can create hundreds of mutations in male germ
cells which are then grown to adulthood and crossed to
wildtype females to create the F1 generation [23]. The F1
generation is outcrossed to obtain F2 generation carriers and
the heterozygous carriers are then incrossed to get the F3
generation to study the homozygous portion of the progeny
for phenotypes [23].
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Point mutations are the most common outcome from this
method [24]. Mutations with ENU have a high mutagenic rate
so there is a higher germline transmission rate to future gen-
erations and the method offers a non-biased approach to iden-
tify genes that previously would have never been implicated
with specific roles [25]. In zebrafish, the first ENU screen
successfully identified over 600 genes with mutant pheno-
types thought to be involved in embryonic development
[11]. However, ENU mutagenesis requires positional cloning
to be undertaken where the disease and candidate gene are
colocalised onto a chromosomal region which is seen as more
laboursome in comparison to other methods [26].
Insertional mutagenesis
This method involves the addition of exogenous DNA, com-
monly pseudotyped retroviruses that can result in around 1 in
80 insertions disrupting gene function and causing a mutant
phenotype [27, 28]. This forward genetic method is typically
used to identify genes associated with a particular phenotype.
This strategy is seen as a better alternative to ethylnitrosourea
(ENU)-induced mutagenesis as the genetic sequence of the
vector provides a distinctive identifier for cloning, making
screening for mutants easier [29, 30].
Reverse genetic approaches
Targeting induced local lesions in genomes
One reverse genetic approach is targeting induced local lesions
in genomes (TILLING) to study a specific gene and combines
the use of chemical mutagenesis with polymerase chain reaction
(PCR) to identify mismatches in mutant and DNA strands dur-
ing annealing. At the mismatch site, a single strand nuclease,
e.g.CEL1 (purified from celery), cleaves theDNAwhich can be
analysed with sequencing methods [31]. Adapting this ap-
proach in zebrafish was initially carried out by Fritz et al. who
used a multiplex PCR to target a number of zebrafish genes to
test on haploid offspring of female fish that were fertilised with
gamma-radiated sperm [32]. The study was able to recover 15
mutants such as the msxB (muscle segment homeobox B) mu-
tant which had no PCR product detected and displayed abnor-
mal phenotypes such as a shortened body axis.
Targeted germline mutations
Engineered endonucleases such as zinc finger nuclease and
transcription activator-like effector nucleases (TALENS) also
emerged as tools to create site-specific genome modification
by introducing double-stranded breaks in a target region. Zinc
finger nucleases (ZFN) are based on the theory of recognition
of a few bases of sequence by each zinc finger and Fokl
(Flavobacterium okeanokoites), an endonuclease, which be-
comes active when it dimerises, causing a double-stranded
break in the DNA. These mutations using TALENS and zinc
finger nucleases are introduced due to inefficient repair of the
double-stranded breaks. TALENS also involves Fokl nucle-
ases but the DNA-binding domain is larger, consisting of con-
served repeats [33]. However, it is not easy to assemble zinc
finger domains to bind to an extended stretch of nucleotides
with high affinity and TALENS can be harder to express into a
cell due to their larger size [34]. Thus, despite the recent ad-
vances in forward genetics, these approaches do have their
limitations.
Clustered regularly interspaced short palindromic repeat
(CRISPR) is a relatively new discovery in genetics, which
has opened the field of gene editing. It had originally been
shown in prokaryotes as a naturally occurring innate defence
system against invading phages and plasmids where it pro-
duces a mature CRISPR RNA (crRNA) complex to recognise
target DNA sequence in the virus and employs Cas 9
(CRISPR associated protein) enzymes to ‘cut’ the target site
[35]. By inducing a double-stranded break in the sequence, it
prevents proliferation of the foreign genetic elements [36].
Unlike morpholinos, which induce transient reductions in
gene expression, CRISPR/Cas 9 results in germline muta-
tions, which may result in more stable phenotypes. Like
morpholinos, CRISPR/Cas9 can also have off-target effects,
although there are tools/methods available to try and minimise
these effects [37, 38]. CRISPR/Cas 9 has currently being im-
plemented to create insertions and deletions (InDels) in the
zebrafish genome successfully to create loss of function
models of targeted genes. It is also possible to ‘knock-in’ a
selected mutation, which is a promising approach to replicate
and assess specific mutations seen in patients.
Discussing specific details of gene manipulation technolo-
gies is beyond the scope of this review and the interested
reader is referred to some recent comprehensive reviews [39,
40] [41, 42].
With reverse genetic methods, targeting genes that have
paralogues in the zebrafish, i.e. homologous duplicate pairs,
can result in challenges in mapping the gene that causes the
phenotype. Zebrafish belong to the teleost group where ap-
proximately 350 million years ago, a genome duplication
event occurred during its early evolution and divergence from
mammalian ancestors [43, 44]. The outcome of this is that
these paralogues, which are closely related to each other in
sequence, can have redundant functions [45]. Thus, there is
often a 2:1 ratio of orthologues between zebrafish and humans
[46]. This can be a challenge for researchers as considerations
need to be taken when working with zebrafish genes that are
duplicated to identify the most likely orthologue to the human
gene of interest, which may involve more methods to analyse
the data. For example, it may not be enough to analyse
BLAST results of zebrafish and human data alone as one
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study found that it could not predict the most appropriate
orthologues in the Msh homeobox 1 (msx) zebrafish family
of genes: msxa, msxb, msxc, msxd and msxe with the human
MSX1 and MSX2 genes [47]. Syntenic regions may provide
more insight into their orthologous relationships [47].
Moreover, despite the evidence of homology, some zebrafish
orthologues may not have the same function as the human
gene. For example, heterozygous and homozygous mutations
in the human granulin (GRN) gene have been linked to
frontotemporal lobar degeneration and neuronal ceroid
lipofuscinosis [48], respectively. However, when zebrafish
orthologues of GRN, grna and grnb, were knocked out either
separately or as a double knockout, the models showed no
differences in regards to morphological and movement phe-
notypes [49].
Currently, the latest version of the zebrafish genome assem-
bly is GRCz10, but the genome assembly is still undergoing
improvements due to some sequencing gaps in the genome
and errors inmapping. Occasionally, the new update can result
in relocation of genomic regions. This can be of special rele-
vance when a mutant line is obtained to study a specific gene
of interest and changes to the genome assembly assign the
retroviral insertion to a different gene than originally assumed.
Gaps in the genome assembly can also lead to challenges in
accurately mapping mutations from insertional mutagenesis.
The zebrafish kidney and the mammalian
kidney
Zebrafish is a freshwater fish and thus, a key function of the
zebrafish kidney is to excrete water and maintain osmoregu-
lation [50]. Yet, there is a close functional analogy between
zebrafish and mammalian kidneys, which makes zebrafish an
excellent model for renal research. Zebrafish can be a useful
organism to study processes such as glomerular filtration and
renal tubular clearance as there is conservation of this mech-
anism from fish to mammals [51].
Zebrafish have a pronephros and despite this being the
most ‘basic kidney’ in vertebrate organisms, it has been
shown to be comparable to the mammalian metanephros
[52]. The zebrafish pronephros is comprised of two nephrons
that derive from bilateral stripes of intermediate mesoderm,
similarly to the mammalian kidney [53]. Two bilateral pro-
nephric ducts are linked with glomeruli located in the midline
of the embryo. The pronephric duct is lined by epithelium
from the glomerulus to the cloaca, which is divided into seg-
ments comparable to themammalian system, such as the prox-
imal and the early distal tubule (Fig. 1) [52]. In addition,
Wingert et al. found that many genes that are localised to
specific segment in the mammalian kidney were also
expressed in the pronephros. For example, solute transporters
slc9a3 and slc4a4 are restricted to the proximal segments in
both zebrafish and mammals and expression of clcnk which
encodes a chloride channel in mammals in the distal regions
are comparable to the clck expression in the distal part of the
pronephros [51]. Like humans, zebrafish have a developed
brush border membrane and also express megalin and cubulin
receptors located in the proximal convoluted tubule segment
to aid reabsorption of salts, sugars and small proteins [54].
While the zebrafish glomerular anatomy is comparable to
the human glomerulus, another difference is that zebrafish
have a mesonephric rather than metanephric adult kidney
and have no bladder [53]. Moreover, the pronephros structure
differs slightly in structure to the more specialised mammalian
metanephros; for example, the pronephros does not have a
thin limb segment between the proximal straight tubule and
the thick ascending limb (equivalent to the zebrafish distal
early segment).
The developing kidney
There is also analogy in kidney development: zebrafish
genes such as pax2.1 (essential for kidney development
in higher vertebrates) are also directing pronephric devel-
opment resulting in the tubular segmentation discussed
above [55]. In the intermediate mesoderm and then pro-
nephric duct, the zebrafish protein Cadherin17,
orthologous to human LI-cadherin (CDH17), is expressed
to ensure the development of apical and basolateral
membrane domains and for cell cohesion within the
ducts [56]. The Notch signalling pathway has been
shown to play a role in the developing pronephric neph-
rons as ligands such as deltaC, jag1b and jag2a are
expressed and restricted to the proximal intermediate me-
soderm [57].The pronephros localisation and segmenta-
tion is mediated by (caudal) cdx transcription factors
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Fig. 1 Schematic representation of the pronephros in the developing
zebrafish. The image shows one pronephric tubule out of the bilateral
organ consisting of the various segments. The distal early tubule is
representative of the thick ascending limb, and the distal late segment is
representative of the distal convoluted tubule in humans. The pronephric
duct is analogous to the collecting duct in humans. The tubular epithelium
then joinswith the cloaca to complete the process. By the 28-somite stage,
the pronephros is developed consisting of two parallel nephrons and
glomerular filtration can commence from 2 days post-fertilisation. G glo-
merulus,N neck, PCT proximal convoluted tubule, PST proximal straight
tubule, DE distal early tubule, CS corpuscles of stannius, DL distal late
tubule, PD pronephric duct
which affect retinoic acid activity by increasing its pro-
duction at the embryonic axis and then forming the pro-
nephros at this site [51].
Zebrafish provided an insight into how nephrons differ-
entiate into segments by studying the pattern of signalling
pathways in both retinoic acid and irx3b. Morpholino
knockdown of irx3b in zebrafish embryos showed lack of
a mature distal segment as well as expansion of the prox-
imal tubule boundaries and oedema at 72 h post-
fertilisation indicating its involvement in demarcating
nephron proximal and distal signals [58].Interestingly,
zebrafish also have the ability to develop new nephrons
(nephrogenesis) in response to injury in their lifespan in
contrast to mammals [59]. By studying nephrogenesis in
the zebrafish, researchers can test molecular pathways for
roles in nephrogenesis, which can subsequently be further
studied in murine models.
Many zebrafish mutant lines exist today in biomedical re-
search that are used to study kidney function and relate the
findings to the human kidney. The Tg(wt1b:EGFP) zebrafish
line [60], for example, enables the fluorescent visualisation of
the proximal tubules and glomerulus via green fluorescent pro-
tein (GFP) (Fig. 2) and was used to show the importance of the
Wilms tumour protein (wt1) in pronephros development, glo-
merular formation and nephrogenesis in zebrafish [60]. This is
similar to its role in humans asWT1 also plays a role in kidney
development in mammals [61]. Mutations in WT1 can lead to
Wilms tumour, a paediatric kidney cancer [62].
Functional assays to study kidney function
There are other tools available to study kidney function. Given
the importance of the kidney for water excretion, the presence
of oedema in a mutant fish can be an indicator of impaired
kidney function. An inherent caveat of the zebrafish model is
that it is often difficult to detect changes in the urine to assess
the clearance of specific markers of interest as it is the level in
the surrounding water rather than the pure urine that can be
examined. Normal renal function tests routinely used in
clinics are challenging to perform in zebrafish, due to small
volumes of urine, and the fact that urine is released into the
surrounding water. This can limit the utility of zebrafish as a
model for specific tubular diseases.
Fluorescent assays have been useful in studying
zebrafish models of kidney function and disease
[63–65]. Typically, fluorescent tracers are injected in
zebrafish embryos so that they can easily be tracked under
a fluorescent microscope within an area of interest. Large
molecular weight tracers are retained by the intact glomer-
ular barrier and thus can be used to study glomerular
function [54] [66, 67]. A transgenic line was developed
to express vitamin D-binding protein tagged to green
fluorescent protein (VDBP-GFP; combined size of ap-
proximately 87 kDa). When crossed with another trans-
genic line in which podocyte damage can be induced, the
double-transgenic fish showed accumulation of VDBP-
GFP within the proximal tubules indicative of a damaged
glomerular filtration barrier (GFB) [68].
In addition, the disappearance rate of a low molecular
weight fluorescent tracer can be used as a rough marker of
glomerular filtrate rate. This technique can comprehensively
be implemented using zebrafish embryos and the kidney
visualised using a fluorescence microscope (Fig. 3).
Impaired glomerular filtration will lead to retention of these
dextrans in the fish, which can be visualised and measured. In
our studies of the kcnj10 morphant for example, we showed
impaired renal clearance of a rhodamine-labelled 10 kDa dex-
tran, when injected into the pericardium of the embryos. The
loss of fluorescence from the fish correlates with the clearance
of the dextran by the kidneys and loss of kcnj10 in these
morphants showed higher levels of fluorescence compared
to controls [69].
Tracers can also be used to assess tubular function, specif-
ically reuptake in the proximal tubule [70, 71]. Another im-
portant aspect of tubular function in zebrafish (a sweetwater
fish) is excretion of water. Consequently, deletion of tubular
transporters can lead to water retention, as we showed in the
abovementioned kcnj10 morphants, which displayed a dilated
pronephric duct and pericardial oedema [69].
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Fig. 2 The developing kidney in a 48-h post-fertilisation zebrafish
embryo. Shown is an image of a transgenic fish Tg(wt1b:EGFP),
expressing the fluorescent protein E-GFP in kidney progenitor cells.
The kidney is seen by its GFP expression, with notable structures
labelled. The pronephric tubules have not yet reached their full length at
this stage of development but will elongate further by 3.5 days post-
fertilisation
Zebrafish as a model of glomerular disease
Zebrafish have helped validate bioinformatic findings from
genome-wide association studies (GWAS), which identify ge-
nomic regions that can then be investigated in the zebrafish. In
one such study, two novel candidate proteins, SOS Ras/Rho
guanine nucleotide exchange factor 2 (SOS2) and acid phos-
phatase 1 (ACPI), were predicted to be involved in early de-
velopment and function of the kidney based on estimated
glomerular filtration rate (eGFR), serum creatinine values
and ‘variants genotyped’ from next generation sequencing.
These patients were recruited from the ‘CKDGen consortium’
to assess the effect of rare variants on chronic kidney disease
as the multiple common genetic risk variants could only ex-
plain a small proportion of variation with eGFR and urinary
albumin-to-creatinine ratio (UACR) measures in these
patients [72].When morpholinos against these genes were
injected into zebrafish embryos, there were morphological
changes in the renal tubule seen, e.g. elongation, and there
was also reduced body length overall of the embryo [72]. To
ensure that these changes were not a result of off-target effects,
the morpholinos directed against the ‘ATG’ start site were
validated with splice site morpholinos which also show simi-
lar phenotypes such as the reduced body length [72]. Embryos
also displayed oedema at 72 h old and when assessed for
glomerular function and tubular flow with injections of
70 kDa rhodamine-labelled dextran, these morphants showed
decreased dextran clearance compared to controls [72]. This
phenotype is also associated with the role of sos2 and acp1 in
kidney development [72]. In humans, mutation with SOS2 is
associated with Noonan syndrome which results in kidney
dysfunction and though there is no current association be-
tween ACP1 and kidney function, it provides a useful target
for further studies into kidney abnormalities.
Nephrotic syndrome has also been studied in zebrafish.
Mutations in genes encoding proteins expressed in the slit
diaphragm have been identified in patients with nephrotic
syndrome, bringing the focus onto podocytes and their inter-
actions during filtration [73, 74]. Mutations in the phospholi-
pase C epilson (plce1) gene, whose normal function is re-
quired to initiate cell growth, differentiation and gene expres-
sion, were shown to cause early onset nephrotic syndrome and
end-stage kidney disease [75]. Essential domains and residues
in the plce1 protein are highly conserved in zebrafish, en-
abling researchers to investigate the role of plce1 in podocyte
function. Morpholinos against the gene orthologue were
injected in zebrafish embryos to assess the journey of a 500-
kDa tracer (FITC-dextran) perfused into the vasculature [75].
The study found that in control fish, there was retention of this
large tracer in the glomerular vasculature and typical morphol-
ogy. However, in plce1 knockdown embryos, there was a
breakdown in the glomerular barrier as expression of the tracer
was visualised in the proximal tubule. Moreover, these embry-
os developed an oedematous phenotype with podocyte efface-
ment classically representative of nephrotic syndromes.
A study of steroid-resistant nephrotic syndrome (SRNS)
identified underlying mutations in the gene FAT1 (FAT atypi-
cal cadherin 1) in some patients [76]. To understand the role of
FAT1 in glomerular function in vivo, the investigators
knocked down fat1 in zebrafish embryos from the transgenic
line Tg(wt1b:EGFP) [76]. This transgenic fish line allows
fluorescent visualisation of the glomerulus and proximal tu-
bules [60].The study revealed that knockdown of fat1 resulted
in pronephric cyst development in morphants. The paper then
investigated the link between fat1 and Rho GTPases. The Rho
GTPases family include RAC1 (Ras-related C3 botulinum
toxin) and CDC42 (Cell division control protein 42 homo-
logue) which are both involved in cellular migration:
CDC42 in particular is involved in filopodia formation and
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Fig. 3 Injection of 10 kDa FITC-dextran into a wild-type zebrafish
embryo at 72 h post-fertilisation visualised on a fluorescence inverted
compound microscope. a Injection of the tracer into the common
cardinal veins taken just after injection, showing uptake of the dextran
into the blood vasculature of the embryo. b Dorsal visualisation of the
dextran being taken up in to the pronephric duct and tubules after 20 h
incubation post injection. Note that the tubules appear convoluted as they
form a coiled loop around the glomerulus (not shown) and show reduced
fluorescence in the rest of the embryo indicative of normal renal filtration
processes
normal tubular function [77]. Knockdown of fat1 in zebrafish
caused a decrease in the amount of active RAC1 and CDC42
available and the addition of RAC1/CD42 was partially able
to rescue the cyst phenotype observed [76]. The study showed
that FAT1 is important for glomerular function as it is involved
in cell migration of renal tubular cells and that activation of
Rho GTPases can correct defective migration in the absence
of FAT1 [76].
The gene ELMO1 had been implicated in the development
of diabetic nephropathy but its function in the nephron was
relatively unknown. The zebrafish orthologue elmo1 is
expressed in the vasculature and in hyperglycaemic condi-
tions, elmo1 knockout mutants (via CRISPR/Cas9 system)
were found to have an abnormal increase in the width of the
pronephric system [78]. Moreover, they also exhibited a larger
glomerulus and abnormal podocyte development. During fil-
tration assays, the injection of 70 kDa dextran in the embry-
onic heart demonstrated abnormal filtration in the mutants
with significant losses of fluorescence over time in compari-
son to CRISPR controls. This is thought to represent
hyperfiltration as seen in early diabetic nephropathy [78].
The study was able to establish the protective effect of elmo1
in diabetic nephropathy on kidney function and structure dur-
ing hyperglycaemic conditions.
Acute kidney injury
Zebrafish have also been used to study the effect of nephro-
toxic agents such as cisplatin and gentamicin. Administration
of these drugs induces oedema in embryos, as well as histo-
logical changes such as brush border flattening and debris in
the tubular lumen [79]. Most importantly, injection of tracers
such as dextran and inulin into these drug-treated zebrafish
showed disturbances in the glomerular filtration rate as clear-
ance is decreased relative to controls [79].
The E3-ubiquitin ligase, murine double-minute (mdm2)
gene, regulates p53 induction and is a promoter of inflamma-
tion. It is also important for maintaining homeostasis of renal
tubular epithelial cells (which normally divide at a slow rate)
so that there is an adequate turnover of cells. Though mdm2
inhibitors are being investigated as anti-cancer drugs [80], a
recent study by Thomasova et al. showed that it also has a
protective effect on renal tubular epithelial cells preventing
acute kidney injury [81]. To test the importance of this gene
in vivo, mdm2 was knocked down using a morpholino ap-
proach in the Tg(wt1b:EGFP) transgenic line where apoptosis
of renal epi thel ia l cel ls measured by a terminal
deoxynucleotidyl transferase (TUNEL (TdT)-mediated
dUTP)) assay was observed as well as increased width of
the pronephric tubules [81]. These morphants also exhibited
pericardial oedema at 2 days old. Knockdown of mdm2 using
another t ransgen ic l ine , CADE (Tg (Casper ; l -
fabp:DBP-EGFP), showed reduced fluorescence in the ves-
sels indicative of a leaky filtration barrier [81]. The study
highlights mdm2 as an important gene for tubular epithelial
homeostasis and survival.
Tubular function
Despite the limitations of zebrafish in the study of tubular
diseases, they have also been used to study disorders with
tubular involvement. As mentioned previously, zebrafish
morphants recapitulated the key features of EAST syndrome,
representing the first zebrafish model of a tubulopathy [69].
More recently, zebrafish were used to study the role of ocrl1
(associated with Lowe syndrome and Dent disease) [82]. The
investigators were able to demonstrate the role of ocrl1 in
proximal tubular function by showing impaired endocytosis
within the pronephric tubules in ocrl1-deficient zebrafish em-
bryos and thus established zebrafish as a useful model for the
study of renal Fanconi syndromes. In another study, ocrl1-
deficient zebrafish embryos also showed brain and eye reduc-
tion in which orcl1 is highly expressed, suggesting a develop-
mental role for this gene within the central nervous system
[83]. Previous work with zebrafish mutants has also provided
evidence of Lowe syndrome as a ciliopathy where antisense
morpholinos targeting the ocrl1 gene showed cystogenesis
and pronephros dilation, typically seen in other cilia-
defective models [84]. Zebrafish were also successfully used
as a model for nephropathic cystinosis, where patients exhibit
renal Fanconi syndrome with progressive glomerular damage
and multiple organ dysfunction [70]. Mutants homozygous
for the ctns (cystinonin) gene showed cystine accumulation,
delayed development and proximal tubular impairment with
signs of glomerular damage recapitulating the patient pheno-
type [70].
Polycystic kidney disease and other
ciliopathies
A panel of zebrafish mutants with cystic kidney phenotypes
identified 12 causative genes, which now constitute candidate
genes for human cystic kidney disease identified by a forward
genetic insertional screen [85]. Previously, the orthologues of
two of the 12 genes, hepatocyte nuclear factor 1 (HNF1) and
polycystic kidney disease 2 (PKD2), had been associated with
human forms of polycystic kidney disease (PKD/PC) [86, 87],
validating this panel approach. Mutations in the polycystins
(PC), i.e. polycystic kidney disease 1 (PKD1) and PKD2,
cause autosomal dominant polycystic kidney disease in
humans [88]. It is thought that there is a ‘two-step’ model in
the initiation cystogenesis consisting of germline mutations
and somatic mutations in PKD in epithelial cells. This then
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results in proliferation of these cells and causes formation of
cysts and tubular dilation.
Zebrafish embryos overexpressing the C-terminal
polycystin fragment, by injection with exogenous mRNA or
DNA, showed a marked ‘dorsalising’ effect where the tissue
in the muscle and pronephric duct development were disrupted
[89]. The study suggested that polycystin-1 modulates the Wnt
signal transduction pathway, cooperating together during vital
stages of renal tubulogenesis [89]. Low et al. also showed that
overexpression of polycystin-1 (via injections of human
polycystin-1 mRNA encoding the PC1 tail into zebrafish em-
bryos) resulted in cysts at 3 days post-fertilisation but with no
‘dorsalising’ effects. Though both studies show different phe-
notypes, they both implicate polycystin 1 as a modulator of the
Wnt pathway, mainly inhibiting glycogen synthase kinase
(GSK-3β) which normally phosphorylates beta-catenin for
subsequent degradation [90, 91].However, the approach of
Low et al. may better recapitulate the renal cyst formation seen
in autosomal dominant polycystic kidney disease.
Morpholinos directed against nphp1, a gene associated with
nephronophthisis, in zebrafish helped to corroborate the finding
that mutations in this gene can contribute to the disease spec-
trum seen in Bardet-Biedl syndrome (BBS), a known
ciliopathy [92]. Moreover, a zebrafish ciliopathy model of
Meckel-Gruber syndrome (in which symptoms include renal
cystic dysplasia) demonstrated the importance of the zebrafish
paralogues meckelin (mks3) and filamin A (flna) in causing the
disease. It was shown that mks3 localises to the primary cilia
and flna is a binding partner that interacts at the apical cell
surface [93]. When these genes were knocked down either
separately or together in the zebrafish, phenotypes showed pro-
nephric cyst formation along with notochord abnormalities
suggesting these genes are also involved inWnt signalling [93].
Zebrafish have also provided cross species conservation of a
mutation in the Nek-family kinases, causing cyst formation in
the connecting segments and cortical collecting ducts of mice
[94]. Mutations in one family member, Nek8, are associated
with polycystic kidney disease [94]. Using a morpholino ap-
proach in the zebrafish, embryos were injected with Nek8 an-
tisense sequence resulting in cystic kidneys as early as 48 h
post-fertilisation, supporting the phenotype seen in mice [94].
This data was able to provide evidence to support observations
seen in vitro where mutated Nek8 showed defects in cytoskel-
etal structures in cell culture and loss of cell adhesion—this is
thought to be a cause of cystic kidney disease.
End-stage renal disease and apolipoprotein 1
Apolipoprotein 1 (APOL1) variants have been shown to in-
crease the risk of progression onto developing end-stage renal
disease (ESRD) [95]. These mutations are more prevalent in
African populations compared to European American
populations because of a protective effect against the African
parasite Trypanosoma brucei rhodesiense infection. In order
to study this further, zebrafish were used as they offer an
advantage over mice models as there is no expression, nor
orthologue, of APOL1 in the mouse and zApol1 is expressed
in zebrafish podocytes. Olabisi et al. showed expression of
these human APOL1 variants (G1 or G2) under the Gal4/
UAS system in transgenic zebrafish resulted in glomeruli ab-
errations as shown by podocyte effacement and endothelial
injury [96]. There was no tubular proteinuria detected via
the renal excretion of GFP-vitamin D-binding protein where
there is accumulation of the tracer within the proximal tubules,
similar to the method employed by Zhou et al., but with pu-
romycin aminonucleoside (PAN) as an inducer of podocyte
injury. The study showed that the transgenic zebrafish ex-
pressing human APOL1 variants did not further potentiate
the glomerular injury induced by PAN so though there were
histological defects, it was not enough to cause renal dysfunc-
tion. The study suggested that presence of these variants may
increase the onset of Apol1 nephropathy but a ‘second hit’
other than PAN may be required to observe kidney dysfunc-
tion [96]. In another study, knock down of the zebrafish
orthologue, zApoL1 in embryos resulted in oedema suggestive
of a leaky filtration barrier [97]. This was confirmed with
coinjection of 500 and 10 kDa dextran—in morphants, the
pronephric tubules showed fluorescence from both markers
after 24 h, whereas only the 10 kDa dextran was visible in
the control pronephric tubules. This study showed the useful-
ness of zebrafish for the study of this gene. Unlike primates, in
which there are up to five additional APOL genes, zebrafish
have only one APOL orthologue eliminating the potential
redundancy effect [97].
Regeneration of the kidney
Zebrafish have also been used to study the possibility of re-
generation after loss of function. It was shown that nephron
progenitor cells can produce new nephrons in the adult
zebrafish [59]. Moreover, using transgenic lines Tg
(wt1b:GFP) and Tg(pod:NTR-mcherry) (the latter being a
red fluorescent marker of glomerular podocytes), the investi-
gators were able to track mesonephric nephrons from the mo-
ment of gentamicin-induced injury to regeneration of the me-
sonephros. They were able to show that expression of one of
the WT1 orthologues, wt1b, influences the development of
new early progenitor cells proliferating into stage 1 nephron
primordia by 4 days after injury in adult zebrafish [98]. When
podocytes are injured via exposure to chemical agents, in this
case MTZ (1-[2-hydroxyethyl]-2-methyl-5-nitroimidazole),
wt1b showed expression in the Bowman’s capsule resulting
in a podocyte-specific response and repair in the mesonephros
[68]. The product of the otherWT1 orthologue, wt1a, also has
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a role along with FoxC1/2 transcription factors and notch
signalling, to promote podocyte formation in zebrafish as
morpholinos against these targets resulted in fewer podocytes
developing.
Conclusion
Various manipulations discussed here such as loss of function
models and use of morpholinos can be implemented in the
zebrafish to study disease states. We can study the impact of
mutations in targeted genes that have a role in renal physiol-
ogy by using zebrafish and use this knowledge to help under-
stand more about the gene’s impact in humans, due to the
genetic similarity. With targeted germline mutations, we can
also assess the effect of specific mutations to assess the path-
ogenicity of genetic variants identified in patients with kidney
disease. Zebrafish can also be used to study the basic renal
physiology. Overall, zebrafish represent a useful model to
study renal function and disease.
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